Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05184933 · ClinicalTrials.gov registry record · NA

Sleep and Circadian Mechanisms in Hypertension

A NA study of Hypertension and Cardiovascular Diseases, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05184933 is a NA study of Hypertension and Cardiovascular Diseases that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 32 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05184933, a NA study of Hypertension and Cardiovascular Diseases, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).

Interventions

  • BEHAVIORAL Regularized Sleep Schedule
  • OTHER At-home Polysomnography
  • OTHER Circadian Protocol
  • OTHER Rested Wakefulness Trial
  • OTHER Overnight Sleep Trial

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-08-04
Est. Completion 2029-03-30
Phase NA

What the Registry Record Tells You About NCT05184933

The ClinicalTrials.gov registry entry for NCT05184933 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 5 interventions - of which Regularized Sleep Schedule is the first listed.

NCT05184933 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05184933 about?

NCT05184933 is a clinical study titled "Sleep and Circadian Mechanisms in Hypertension". This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).

What is the current status of trial NCT05184933?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-08-04. Estimated completion is 2029-03-30.

What conditions does trial NCT05184933 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Sleep, Cardiovascular Risk Factors, Circadian Rhythms.

What interventions are being tested in trial NCT05184933?

The interventions under investigation include: Regularized Sleep Schedule (BEHAVIORAL), At-home Polysomnography (OTHER), Circadian Protocol (OTHER), Rested Wakefulness Trial (OTHER), Overnight Sleep Trial (OTHER).

Who is sponsoring clinical trial NCT05184933?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05184933 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.